The BCR-ABL fusion protein is not solely required for LSC survival; thereby, TKIs fail to annihilate LSCs responsible for CML maintenance [666]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.